124 related articles for article (PubMed ID: 17572302)
1. Molecular alterations during insulinoma tumorigenesis.
Jonkers YM; Ramaekers FC; Speel EJ
Biochim Biophys Acta; 2007 Jun; 1775(2):313-32. PubMed ID: 17572302
[TBL] [Abstract][Full Text] [Related]
2. Chromosomal instability predicts metastatic disease in patients with insulinomas.
Jonkers YM; Claessen SM; Perren A; Schmid S; Komminoth P; Verhofstad AA; Hofland LJ; de Krijger RR; Slootweg PJ; Ramaekers FC; Speel EJ
Endocr Relat Cancer; 2005 Jun; 12(2):435-47. PubMed ID: 15947114
[TBL] [Abstract][Full Text] [Related]
3. Mutation of the MENIN gene in sporadic pancreatic endocrine tumors.
Wang EH; Ebrahimi SA; Wu AY; Kashefi C; Passaro E; Sawicki MP
Cancer Res; 1998 Oct; 58(19):4417-20. PubMed ID: 9766672
[TBL] [Abstract][Full Text] [Related]
4. Gene expression profiling in insulinomas of Men1 beta-cell mutant mice reveals early genetic and epigenetic events involved in pancreatic beta-cell tumorigenesis.
Fontanière S; Tost J; Wierinckx A; Lachuer J; Lu J; Hussein N; Busato F; Gut I; Wang ZQ; Zhang CX
Endocr Relat Cancer; 2006 Dec; 13(4):1223-36. PubMed ID: 17158767
[TBL] [Abstract][Full Text] [Related]
5. DNA copy number status is a powerful predictor of poor survival in endocrine pancreatic tumor patients.
Jonkers YM; Claessen SM; Perren A; Schmitt AM; Hofland LJ; de Herder W; de Krijger RR; Verhofstad AA; Hermus AR; Kummer JA; Skogseid B; Volante M; Voogd AC; Ramaekers FC; Speel EJ
Endocr Relat Cancer; 2007 Sep; 14(3):769-79. PubMed ID: 17914106
[TBL] [Abstract][Full Text] [Related]
6. Insulinomatosis: a multicentric insulinoma disease that frequently causes early recurrent hyperinsulinemic hypoglycemia.
Anlauf M; Bauersfeld J; Raffel A; Koch CA; Henopp T; Alkatout I; Schmitt A; Weber A; Kruse ML; Braunstein S; Kaserer K; Brauckhoff M; Dralle H; Moch H; Heitz PU; Komminoth P; Knoefel WT; Perren A; Klöppel G
Am J Surg Pathol; 2009 Mar; 33(3):339-46. PubMed ID: 19011561
[TBL] [Abstract][Full Text] [Related]
7. Genetic evidence for early divergence of small functioning and nonfunctioning endocrine pancreatic tumors: gain of 9Q34 is an early event in insulinomas.
Speel EJ; Scheidweiler AF; Zhao J; Matter C; Saremaslani P; Roth J; Heitz PU; Komminoth P
Cancer Res; 2001 Jul; 61(13):5186-92. PubMed ID: 11431358
[TBL] [Abstract][Full Text] [Related]
8. Oncogenic co-operation in beta-cell tumorigenesis.
Pelengaris S; Khan M
Endocr Relat Cancer; 2001 Dec; 8(4):307-14. PubMed ID: 11733227
[TBL] [Abstract][Full Text] [Related]
9. Insulinoma in childhood: a retrospective review of 22 patients from one referral centre.
Melikyan M; Gubaeva D; Shadrina A; Bolmasova A; Kareva M; Tiulpakov A; Efremenkov A; Sokolov Y; Brusgaard K; Christesen HT; Andersen K; Stepanov A; Averyanova J; Makarov S; Gurevich L
Front Endocrinol (Lausanne); 2023; 14():1127173. PubMed ID: 37152923
[TBL] [Abstract][Full Text] [Related]
10. Chromosome 1q loss of heterozygosity frequently occurs in sporadic insulinomas and is associated with tumor malignancy.
Yang YM; Liu TH; Chen YJ; Jiang WJ; Qian JM; Lu X; Gao J; Wu SF; Sang XT; Chen J
Int J Cancer; 2005 Nov; 117(2):234-40. PubMed ID: 15900598
[TBL] [Abstract][Full Text] [Related]
11. Histologic and Molecular Profile of Pediatric Insulinomas: Evidence of a Paternal Parent-of-Origin Effect.
Bhatti TR; Ganapathy K; Huppmann AR; Conlin L; Boodhansingh KE; MacMullen C; Becker S; Ernst LM; Adzick NS; Ruchelli ED; Ganguly A; Stanley CA
J Clin Endocrinol Metab; 2016 Mar; 101(3):914-22. PubMed ID: 26756113
[TBL] [Abstract][Full Text] [Related]
12. Laparoscopic management of insulinoma in a child with multiple endocrine neoplasia type 1.
de Vogelaere K; De Schepper J; Vanhoeij M; De Mey J; Goossens A; Vanbesien J; De Backer A; Delvaux G
J Laparoendosc Adv Surg Tech A; 2006 Jun; 16(3):335-8. PubMed ID: 16796455
[TBL] [Abstract][Full Text] [Related]
13. Novel MEN 1 gene findings in rare sporadic insulinoma--a case control study.
Jyotsna VP; Malik E; Birla S; Sharma A
BMC Endocr Disord; 2015 Aug; 15():44. PubMed ID: 26307114
[TBL] [Abstract][Full Text] [Related]
14. Molecular genetics of malignant insulinoma.
Pavelic K; Hrascan R; Kapitanovic S; Vranes Z; Cabrijan T; Spaventi S; Korsic M; Krizanac S; Li YQ; Stambrook P; Gluckman JL; Pavelic ZP
Anticancer Res; 1996; 16(4A):1707-17. PubMed ID: 8712689
[TBL] [Abstract][Full Text] [Related]
15. Enucleation and limited pancreatic resection provide long-term cure for insulinoma in multiple endocrine neoplasia type 1.
Bartsch DK; Albers M; Knoop R; Kann PH; Fendrich V; Waldmann J
Neuroendocrinology; 2013; 98(4):290-8. PubMed ID: 24356648
[TBL] [Abstract][Full Text] [Related]
16. Molecular parameters associated with insulinoma progression: chromosomal instability versus p53 and CK19 status.
Jonkers YM; Claessen SM; Veltman JA; Geurts van Kessel A; Dinjens WN; Skogseid B; Ramaekers FC; Speel EJ
Cytogenet Genome Res; 2006; 115(3-4):289-97. PubMed ID: 17124412
[TBL] [Abstract][Full Text] [Related]
17. Pancreatic insulinomas in multiple endocrine neoplasia, type I knockout mice can develop in the absence of chromosome instability or microsatellite instability.
Scacheri PC; Kennedy AL; Chin K; Miller MT; Hodgson JG; Gray JW; Marx SJ; Spiegel AM; Collins FS
Cancer Res; 2004 Oct; 64(19):7039-44. PubMed ID: 15466197
[TBL] [Abstract][Full Text] [Related]
18. Analysis of 55 patients with multiple endocrine neoplasia type 1-associated insulinoma from a single center in China.
Zhao Y; Yu J; Liu Y; Lyu L; Ping F; Xu L; Li W; Wang O; Xu Q; Wu W; Zhang H; Li Y
Orphanet J Rare Dis; 2022 Jun; 17(1):219. PubMed ID: 35698198
[TBL] [Abstract][Full Text] [Related]
19. Somatic mutations of the MEN1 tumor suppressor gene in sporadic gastrinomas and insulinomas.
Zhuang Z; Vortmeyer AO; Pack S; Huang S; Pham TA; Wang C; Park WS; Agarwal SK; Debelenko LV; Kester M; Guru SC; Manickam P; Olufemi SE; Yu F; Heppner C; Crabtree JS; Skarulis MC; Venzon DJ; Emmert-Buck MR; Spiegel AM; Chandrasekharappa SC; Collins FS; Burns AL; Marx SJ; Lubensky IA
Cancer Res; 1997 Nov; 57(21):4682-6. PubMed ID: 9354421
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior.
Roldo C; Missiaglia E; Hagan JP; Falconi M; Capelli P; Bersani S; Calin GA; Volinia S; Liu CG; Scarpa A; Croce CM
J Clin Oncol; 2006 Oct; 24(29):4677-84. PubMed ID: 16966691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
